BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average daily volume of 47,100 shares, the days-to-cover ratio is presently 1.2 days.

BetterLife Pharma Stock Performance

BetterLife Pharma stock opened at $0.11 on Tuesday. BetterLife Pharma has a 52-week low of $0.05 and a 52-week high of $0.30. The firm has a 50 day moving average price of $0.09 and a two-hundred day moving average price of $0.12.

BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last released its quarterly earnings results on Tuesday, June 28th. The company reported ($0.03) earnings per share (EPS) for the quarter.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.

Featured Stories

• Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
• Green Your Portfolio With These Stocks
• Bloomin' Brands Is Blossoming
• Is it Time to Cash Out of Signet Jewelers Stock?
• MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
• Deep Value High Yield Newell Brands Is Ready To Bottom

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.